An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. Continue Reading Category:Illnesses and conditions, Body and Mind Tags:Type 1 diabetes, Diabetes, clinical trials, The Immune System, UZ Leuven
